| 2014年 |
| Nishide T, Hayakawa N, Kimura I, Nakanishi M, Yagi Y,
Shibuya E, Mizuki N: Postoperative refractive error following cataract
surgery after the first attack of acute primary angle closure. Int
Ophthalmol. 34(4): 805-808, 2014. |
| Kaburaki T, Namba K, Sonoda K, Kezuka T, Keino H, Ito T,
Kamoi K, Nakai K, Mizuki N, Ohguro N and the Ocular Behçet Disease
Research Group of Japan. Behçet’s disease ocular attack score 24:
Evaluation of ocular disease activity before and after initiation of
infliximab. Jpn J Ophthalmology 58(2): 120-130, 2014. |
| Nakasato H, Uemoto R, Meguro A, Kawagoe T, Hatano H, Mizuki
N: Treatment of symptomatic inferior conjunctivochalasis by ligation.
Acta Ophthalmol. 92(5): e411-e412, 2014. |
| Nishide T, Hayakawa N, Shibuya E, Yagi Y, Mizuki N:
Choroidal thickness is affected by many factors which may change the
effect of ranibizumab: author's response. Graefes Arch Clin Exp
Ophthalmol. 252(5): 849-850, 2014. |
| Nakasato H, Uemoto R, Isozaki M, Meguro A, Kawagoe T, Mizuki
N: Trabeculotomy ab interno with internal limiting membrane forceps for
open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol. 252(6): 977-82, 2014. |
| Takeuchi M, Kezuka T, Sugita S, Keino H, Namba K, Kaburaki T, Maruyama K, Nakai K, Hirooka K, Hori J, Ohguro N, Sonoda K, Mizuki N, Okada AA, Goto H, Mochizuki M: Evaluation of long-term efficacy and safety of infliximab treatment for uveitis in Behçet's disease: a multicenter study. Ophthalmology. 121(10): 1877-1884, 2014. |
| Bakir-Gungor B, Remmers EF, Megura A, Mizuki N, Kastner DL,
Gul A, Sezerman OU: Identification of Possible Pathogenic Pathways in
Behçet’s Disease Using Genome-wide Association Study Data from Two
Different Populations. Eur J Hum Genet. 23(5): 678-687, 2014. |
| Joshita S, Umemura T, Ota M, Tanaka E. AST/platelet ratio index
associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary biliary cirrhosis.
J Hepatol. 61(6): 1443-1445, 2014. |
| Umemura T, Katsuyama Y, Yoshizawa K, Kimura T, Joshita S, Komatsu M,
Matsumoto A, Tanaka E, Ota M. Human leukocyte antigen class II haplotypes
affects clinical characteristics and progression of type 1 autoimmune hepatitis
in Japan. PLoS One. 9(6): e100565, 2014. |
| Umemura T, Ota M, Katsuyama Y, Wada S, Mori H, Maruyama A,
Shibata S, Nozawa Y, Kimura T, Morita S, Joshita S, Komatsu M, Matsumoto A,
Kamijo A, Kobayashi M, Takamatsu M, Yoshizawa K, Kiyosawa K, Tanaka E.
KIR3DL1-HLA-Bw4 combination and IL28B polymorphism predict response to Peg-IFN
and ribavirin with and without telaprevir in chronic hepatitis C. Hum Immunol.
75(8): 822-826. 2014. |
| Nozawa Y, Umemura T, Katsuyama Y, Shibata S, Kimura T, Morita S,
Joshita S, Komatsu M, Matsumoto A, Yoshizawa K, Ota M, Tanaka E. Genetic
polymorphism in IFNL4 and response to pegylated interferon-α and ribavirin in
Japanese chronic hepatitis C patients. Tissue Antigens. 83(1): 45-48. 2014. |
| Joshita S, Umemura T, Nakamura M, Katsuyama Y, Shibata S, Kimura
T, Morita S, Komatsu M, Matsumoto A, Yoshizawa K, Ishibashi H, Tanaka E, Ota M.
STAT4 gene polymorphisms are associated with susceptibility and ANA status in
primary biliary cirrhosis. Dis Markers. 2014: 727393. |
| Ozaki Y, Suzuki S, Shigenari A, Okudaira Y, Kikkawa E, Oka A, Ota
M, Mitsunaga S, Kulski JK, Inoko H, Shiina T. HLA-DRB1, -DRB3, -DRB4 and -DRB5
genotyping at a super-high resolution level by long range PCR and
high-throughput sequencing. Tissue Antigens. 83(1): 10-16, 2014. |
| Okuhara S, Umemura T, Joshita S, Shibata S, Kimura T, Morita S,
Komatsu M, Matsumoto A, Yoshizawa K, Katsuyama Y, Ota M, Tanaka E. Serum levels
of interleukin-22 and hepatitis B core-related antigen are associated with
treatment response to entecavir therapy in chronic hepatitis B. Hepatol Res.
44(10): E172-80, 2014. |
| Harayama Y, Kamei S, Sato N, Hayashi T, Shiozaki T, Ota M, Asamura
H. Analysis of Y chromosome haplogroups in Japanese population using short
amplicons and its application in forensic analysis. Leg Med (Tokyo). 16(1):
20-25, 2014. |
